IP Library Patent Application 11540095
Patent Application
App. No. 11/540,095

Cell or drug encapsulation device having a wet seal

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/540,095
Abstract

A biologically implantable containment device having a wet seal, the device being adaptable for drug formulations or cell suspensions. A porous membrane, in a tubular configuration, is formed and can be configured as part of a closed cell-tight system for loading. During loading, the containment device membrane is wet, while the loading system remains cell-tight. The containment device is wet-sealed through a combination of heat and pressure, while the system remains cell-tight. Sealing the containment device substantially or completely eliminates metabolic functioning of any organisms in the vicinity of the closure. The wet-seal is formed by melting a thermoplastic material that is in contact with the membrane. The containment device is separated from the cell-tight loading system, which remains closed after separation.

Claims (19)

1 . A cell containment device comprising:

a permeable membrane delimiting a space for containing cells therein;

a closure region comprising a thermoplastic polymer in association with the permeable membrane and means for placing cells in said space through said closure region;

wherein said closure region is closeable with a wet seal.

2 . A containment device comprising:

a membrane;

a polymer in communication with the membrane; and

at least one closure, the closure created by applying heat to a portion of the membrane and to a portion of the polymer after wetting the membrane with a liquid.

3 . A device according to claim 2 , further comprising a cell suspension within a space enclosed by the membrane.

4 . A device according to claim 2 , further comprising a drug formulation within a space enclosed by the membrane.

5 . A device according to claim 2 , wherein the membrane includes a polymer membrane.

6 . A device according to claim 2 , wherein the membrane includes a porous PTFE membrane.

7 . A device according to claim 2 , wherein the membrane substantially surrounds the polymer.

8 . A device according to claim 2 , wherein the membrane is substantially tubular.

9 . A device according to claim 2 , further comprising a closure on a first end of the tubular membrane and the closure created by applying heat is on a second end of the tubular membrane.

10 . A device according to claim 2 , wherein the polymer includes FEP.

11 . A device according to claim 2 , wherein the polymer is distinct from the membrane.

12 . A device according to claim 2 , wherein the closure is substantially part of the polymer.

13 . A device according to claim 2 , wherein the closure is substantially separate from the membrane.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2012
From: GORE ENTERPRISE HOLDINGS, INC.
To: W. L. GORE & ASSOCIATES, INC.
Reel/Frame 027906/0508 →